医学
食管鳞状细胞癌
内科学
肿瘤科
新辅助治疗
放化疗
化疗
基底细胞
免疫疗法
癌
癌症
乳腺癌
作者
Yongkui Yu,Fanyu Meng,Xiufeng Wei,Xiankai Chen,Haomiao Li,Qi Liu,Can-jun Li,Hounai Xie,Lei Xu,Rui‐xiang Zhang,Wenqun Xing,Yin Li
标识
DOI：10.1016/j.jtcvs.2023.12.030
摘要
To date, few studies have compared effectiveness and survival rates of neoadjuvant chemotherapy combined with immunotherapy (NACI) and conventional neoadjuvant chemoradiotherapy (NCRT) in patients with locally advanced esophageal squamous cell carcinoma (ESCC). The present study was conducted to compare therapeutic response and survival between NACI and NCRT.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
v0id
Yinxb
DW
林狗
xing_xing
cocohan
璐璐
123
OK
aaaa
aajhajkahna
蓝天
invisight
极限001
乐空思
huanhuanhuan
wch666
用户LmBowa
渡人舟
七听
皖公网安备34019202002308
